Published in Biotech Business Week, January 3rd, 2005
Actual testing will start next week. With the approvals just received in China and India, the company has significant amounts of test that can be used for regulatory approval in the Ukraine. Some testing within the Ukraine is required by regulatory authorities.
The company feels that the testing completed in China and India that resulted in the approval of the HIV test kits in these countries combined with the testing being done in the Ukraine will result in regulatory approval in the Ukraine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.